GRFS
Price:
$8.8
Market Cap:
$6.43B
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2011-06-02
Stock Exchange
NASDAQ
Ticker
GRFS
According to Grifols, S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 33.85. This represents a change of -21.55% compared to the average of 43.15 of the last 4 quarters.
The mean historical PE Ratio of Grifols, S.A. over the last ten years is 30.76. The current 33.85 PE Ratio has changed 10.90% with respect to the historical average. Over the past ten years (40 quarters), GRFS's PE Ratio was at its highest in in the June 2020 quarter at 81.19. The PE Ratio was at its lowest in in the February 2023 quarter at -171.09.
Average
30.76
Median
20.30
Minimum
16.70
Maximum
119.74
Discovering the peaks and valleys of Grifols, S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 363.08%
Maximum Annual PE Ratio = 119.74
Minimum Annual Increase = -26.64%
Minimum Annual PE Ratio = 16.70
Year | PE Ratio | Change |
---|---|---|
2023 | 119.74 | 363.08% |
2022 | 25.86 | 2.38% |
2021 | 25.26 | 51.26% |
2020 | 16.70 | -26.64% |
2019 | 22.76 | 23.88% |
2018 | 18.37 | -8.70% |
2017 | 20.12 | 5.28% |
2016 | 19.11 | -0.50% |
2015 | 19.21 | -6.14% |
2014 | 20.47 | -20.91% |
The current PE Ratio of Grifols, S.A. (GRFS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
56.95
5-year avg
42.06
10-year avg
30.76
Grifols, S.A.’s PE Ratio is greater than Novartis AG (12.63), less than AstraZeneca PLC (34.38), greater than GSK plc (23.14), greater than Roche Holding AG (13.63), greater than Bristol-Myers Squibb Company (-15.49), greater than Merck & Co., Inc. (21.31), less than Gilead Sciences, Inc. (106.39), less than Amgen Inc. (40.23), greater than Biogen Inc. (15.64), greater than Sanofi (15.43),
Company | PE Ratio | Market cap |
---|---|---|
12.63 | $216.23B | |
34.38 | $221.47B | |
23.14 | $75.40B | |
13.63 | $257.13B | |
-15.49 | $112.46B | |
21.31 | $258.22B | |
106.39 | $111.85B | |
40.23 | $170.35B | |
15.64 | $25.29B | |
15.43 | $132.76B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Grifols, S.A.'s PE Ratio?
How is the PE Ratio calculated for Grifols, S.A. (GRFS)?
What is the highest PE Ratio for Grifols, S.A. (GRFS)?
What is the 3-year average PE Ratio for Grifols, S.A. (GRFS)?
What is the 5-year average PE Ratio for Grifols, S.A. (GRFS)?
How does the current PE Ratio for Grifols, S.A. (GRFS) compare to its historical average?